EXHIBIT ESales Plan • September 7th, 2016 • Sofinnova Venture Partners Vii L P • Biological products, (no disgnostic substances)
Sales Plan, adopted August 26, 2016 (the “Sales Plan”), between Sofinnova Venture Partners VII, L.P. (“Seller”) and J.P. Morgan Securities LLC (“JPMS”). The purpose of this Sales Plan is to achieve the investment objectives of broader diversification of investments, while reducing the risk of over concentration in a particular investment.
